About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Anteris Technologies Global Corp.

News headline image
Anteris Reports 2025 Financial Results and Provides Corporate Update
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris to Present at Healthcare Investor Conferences TD Cowen and Barclays
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Announces Strategic Investment from Medtronic to Continue Advancing TAVR in $320 Million Aggregate Capital Raises
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR MDT
News headline image
Anteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common Stock
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Technologies Global Corp. Announces Proposed $200 Million Public Offering of Common Stock and Strategic Investment from Medtronic
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Technologies Presents Data from 100 DurAVR® THV Patients at PCR London Valves
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Announces Results for the Third Quarter of 2025
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
FDA Approves Anteris’s DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris DurAVR® THV Demonstrates Favorable Hemodynamics in Small Annuli Patients with no Valve Related Mortality at One Year
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Technologies Announces First Patients Treated in DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR® THV to be Presented at TCT® 2025
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Receives First European Regulatory Clearance to Commence DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Technologies Global Corp. Announces Adjournment of Special Meeting of Stockholders
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Announces Results for the Second Quarter of 2025
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Appoints David Roberts and Gregory Moss to its Board of Directors
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR LMAT
News headline image
Anteris Announces Results for the First Quarter of 2025
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Reports One-Year Patient Outcomes for DurAVR® THV
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Reports 2024 Financial Results and Provides Corporate Update
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris to Present at Healthcare Investor Conferences - TD Cowen and Barclays
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Technologies Global Corp. Announces Closing of $88.8 Million U.S. Initial Public Offering
From Anteris Technologies Global Corp.
Via Business Wire
Tickers ASX:AVR AVR
News headline image
Anteris Technologies Global Corp. Announces Pricing of U.S. Initial Public Offering
From Anteris Technologies Global Corp.
Via Business Wire
Tickers ASX:AVR
News headline image
Anteris Technologies Global Corp. Announces Launch of U.S. Initial Public Offering
From Anteris Technologies Global Corp.
Via Business Wire
Tickers ASX:AVR
News headline image
Anteris Technologies Global Corp. Files Registration Statement for Proposed US Initial Public Offering
From Anteris Technologies Global Corp.
Via Business Wire
Tickers ASX:AVR
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.